• Title/Summary/Keyword: Heart Diseases

Search Result 1,269, Processing Time 0.031 seconds

Application of CRISPR-Cas9 gene editing for congenital heart disease

  • Seok, Heeyoung;Deng, Rui;Cowan, Douglas B.;Wang, Da-Zhi
    • Clinical and Experimental Pediatrics
    • /
    • v.64 no.6
    • /
    • pp.269-279
    • /
    • 2021
  • Clustered regularly interspaced short palindromic repeats and CRISPR-associated protein 9 (CRISPR-Cas9) is an ancient prokaryotic defense system that precisely cuts foreign genomic DNA under the control of a small number of guide RNAs. The CRISPR-Cas9 system facilitates efficient double-stranded DNA cleavage that has been recently adopted for genome editing to create or correct inherited genetic mutations causing disease. Congenital heart disease (CHD) is generally caused by genetic mutations such as base substitutions, deletions, and insertions, which result in diverse developmental defects and remains a leading cause of birth defects. Pediatric CHD patients exhibit a spectrum of cardiac abnormalities such as septal defects, valvular defects, and abnormal chamber development. CHD onset occurs during the prenatal period and often results in early lethality during childhood. Because CRISPR-Cas9-based genome editing technology has gained considerable attention for its potential to prevent and treat diseases, we will review the CRISPR-Cas9 system as a genome editing tool and focus on its therapeutic application for CHD.

Effects of omega-3 fatty acids, vitamins, and chelation therapy in patients with heart diseases (심질환 환자에서 오메가-3 지방산, 비타민, 킬레이션 요법의 효과)

  • Joo, Seung-Jae
    • Journal of Medicine and Life Science
    • /
    • v.18 no.1
    • /
    • pp.1-10
    • /
    • 2021
  • Omega-3 fatty acids (eicosapentaenoic acid [EPA] and docosahexaenoic acid [DHA]) may be beneficial for the primary and secondary prevention of cardiovascular events (CVEs), especially in patients with myocardial infarction or heart failure with reduced ejection fraction. For this purpose, one to two seafood meals per week is preferentially recommended. Omega-3 fatty acids with a high-dose EPA formula (4 g/day) may be more effective than EPA+DHA mixed supplements for the secondary prevention of CVE. Krill oil also contains omega-3 fatty acids, but at a much lower dose compared to fish oil. Supplemental vitamins and minerals have not shown the preventive effects on CVE in prospective, and randomized clinical trials, except for one Chinese study showing the stroke prevention effects of folic acid. The clinical benefit of chelation therapy in reducing CVEs is uncertain.

Heart Attack Prediction using Neural Network and Different Online Learning Methods

  • Antar, Rayana Khaled;ALotaibi, Shouq Talal;AlGhamdi, Manal
    • International Journal of Computer Science & Network Security
    • /
    • v.21 no.6
    • /
    • pp.77-88
    • /
    • 2021
  • Heart Failure represents a critical pathological case that is challenging to predict and discover at an early age, with a notable increase in morbidity and mortality. Machine Learning and Neural Network techniques play a crucial role in predicting heart attacks, diseases and more. These techniques give valuable perspectives for clinicians who may then adjust their diagnosis for each individual patient. This paper evaluated neural network models for heart attacks predictions. Several online learning methods were investigated to automatically and accurately predict heart attacks. The UCI dataset was used in this work to train and evaluate First Order and Second Order Online Learning methods; namely Backpropagation, Delta bar Delta, Levenberg Marquardt and QuickProp learning methods. An optimizer technique was also used to minimize the random noise in the database. A regularization concept was employed to further improve the generalization of the model. Results show that a three layers' NN model with a Backpropagation algorithm and Nadam optimizer achieved a promising accuracy for the heart attach prediction tasks.

The Case-Control Study on the Risk Factors of Cerebrovascular Diseases and Coronary Heart Diseases (뇌혈관질환과 관상동맥성 심질환의 위험요인에 관한 환자-대조군 연구)

  • Park, Jog-Ku;Kim, Hun-Joo;Park, Keum-Soo;Lee, Sung-Su;Chang, Sei-Jin;Shin, Kye-Chul;Kwon, Sang-Ok;Ko, Sang-Baek;Lee, Eun-Kyoung
    • Journal of Preventive Medicine and Public Health
    • /
    • v.29 no.3 s.54
    • /
    • pp.639-655
    • /
    • 1996
  • Cerebrovascular disease and coronary heart disease are the first and the fourth common causes of death among adults in Korea. Reported risk factors of these diseases are mostly alike. But some risk factors of one of these diseases may prevent other diseases. Therefore, we tried to compare and discriminate the risk factors of these diseases. We recruited four case groups and four control groups among the inpatients who were admitted to Wonju Christian Hospital from March, 1994 to November, 1995. Four control groups were matched with each of four case groups by age and sex. The number of patients in each of four case and control groups were 106 and 168 for acute myocardial infarction(AMI), 84 and 133 for subarachnoid hemorrhage(SAH), 102 and 148 for intracerebral hemorrhage(ICH), and 91 and 182 for ischemic stroke(IS) respectively. Factors whose levels were significantly higher in AMI and IS than in responding control group (RCG) were education, economic status, and triglyceride. Factors whose levels were significantly lower in hemorrhagic stroke than in RCG were age of monarch, and prothrombin time. The factor whose level was higher in AMI than ill RCG was uric acid. The factor whose level was higher in AMI, ICH, and SAM than in RCG was blood sugar. Factors whose levels were significantly higher in all the case groups than in RCG were earlobe crease, Quetelet index, white blood cell count, hemoglobin, hematocrit, and total cholesterol. The list of risk factors were somewhat different among the four diseases, though none of the risk factors to the one disease except prothrombin time acted as a preventive factor to the other diseases. The percent of grouped cases correctly classified was higher in the discrimination of ischemic diseases(AMI and IS) from hemorrhagic diseases(SAM and ICH) than in the discrimination of cerebrovascular disease from AMI. The factors concerned in the discrimination of ischemic diseases from hemorrhagic diseases were prothrombin time, earlobe crease, gender, age, uric acid, education, albumin, hemoglobin, the history of taking steroid, total cholesterol, and hematocrit according to the selection order through forward selection.

  • PDF

Studies on Symptomatic Criteria and Sexual Differences of Liver.Heart.Pancreas.Lung.Kidney Diseases based on Questionnaire (설문지 분석법에 의한 간(肝).심(心).비(脾).폐(肺).신병(腎病)의 표준(標準) 증상(症狀) 및 남여차이(男女差異) 연구(硏究))

  • Kwon, Hyuck;Lee, In-Seon;Kim, Kyu-Gon;Kim, Jong-Won;Eom, Hyun-Sup;Chi, Gyoo-Yong
    • Journal of Physiology & Pathology in Korean Medicine
    • /
    • v.20 no.4
    • /
    • pp.1057-1062
    • /
    • 2006
  • In order to research the interrelationship of symptoms of 5 visceral diseases through Pearson's correlative coefficient and to understand the diagnostic importances of each symptom and sexual differences in the main symptoms of each visceral diseases using Cronbach alpha. For this 500 female and 120 male cases of questionnaire were collected and analyzed. In the main symptoms of 5 visceral diseases, there were a little differences between this results and existing symptom-complex system. And in the comparison of most frequently manifesting symptoms to male and female subject, Heart and Pancreas and Kidney disease were almost same, but Liver disease was different and Lung disease was slightly different. Conclusively, the diagnostic reliability of the abstracted symptom-complex of 5 viscera was graded from Kidney(Cronbach alpha 0.8771555), Pancreas(0.865978), Liver(0.815013), Heart(0.78653) to Lung disease(0.6294695) sequentially. And the each Cronbach alpha was valuable to be permitted as diagnostic criteria of 5 visceral diseases.

Imaging Hypoxic Myocardium (심근 저산소증 영상)

  • Bae, Sang-Kyun
    • The Korean Journal of Nuclear Medicine
    • /
    • v.39 no.2
    • /
    • pp.141-145
    • /
    • 2005
  • Hypoxia (decreased tissue oxygen tension) is a component of many diseases such as tumors, cerebrovascular diseases and ischemic heart diseases. Although hypoxia can be secondary to a low inspired $pO_2$ or a variety of lung disorders, the most common cause is ischemia due to an oxygen demand greater than the local oxygen supply. In the heart tissue, hypoxia is often observed in persistent low-flow states, such as hibernating myocardium. Direct "hot spot" imaging of myocardial tissue hypoxia is potentially of great clinical importance because it may provide a means of identifying dysfunctional chronically ischemic but viable hibernating myocardium. A series of radiopharmaceuticals that incorporate nitroimidazole moieties have been synthesized to detect decreased local tissue pO2. In contrast to agents that localize in proportion to perfusion, these agents concentrate in hypoxic tissue. However, the ideal agents are not developed yet and the progress is very slow. Furthermore, the research focus is on tumor hypoxia nowadays. This review introduces the myocardial hypoxia imaging with summarizing the development of radiopharmaceuticals.

Effects and Mechanisms of Taurine as a Therapeutic Agent

  • Schaffer, Stephen;Kim, Ha Won
    • Biomolecules & Therapeutics
    • /
    • v.26 no.3
    • /
    • pp.225-241
    • /
    • 2018
  • Taurine is an abundant, ${\beta}-amino$ acid with diverse cytoprotective activity. In some species, taurine is an essential nutrient but in man it is considered a semi-essential nutrient, although cells lacking taurine show major pathology. These findings have spurred interest in the potential use of taurine as a therapeutic agent. The discovery that taurine is an effective therapy against congestive heart failure led to the study of taurine as a therapeutic agent against other disease conditions. Today, taurine has been approved for the treatment of congestive heart failure in Japan and shows promise in the treatment of several other diseases. The present review summarizes studies supporting a role of taurine in the treatment of diseases of muscle, the central nervous system, and the cardiovascular system. In addition, taurine is extremely effective in the treatment of the mitochondrial disease, mitochondrial encephalopathy, lactic acidosis, and stroke-like episodes (MELAS), and offers a new approach for the treatment of metabolic diseases, such as diabetes, and inflammatory diseases, such as arthritis. The review also addresses the functions of taurine (regulation of antioxidation, energy metabolism, gene expression, ER stress, neuromodulation, quality control and calcium homeostasis) underlying these therapeutic actions.

Age-period-cohort Analysis of Cardiovascular Disease Mortality in Japan, 1995-2018

  • Okui, Tasuku
    • Journal of Preventive Medicine and Public Health
    • /
    • v.53 no.3
    • /
    • pp.198-204
    • /
    • 2020
  • Objectives: This study aimed to analyze the mortality of heart disease (HD), ischemic heart disease (IHD), and cerebrovascular disease (CeVD) through an age-period-cohort (APC) analysis. Methods: We used data on mortality due to cardiovascular disease from 1995 to 2018 in Japan, as determined by Vital Statistics. Age groups from 0 years to 99 years were defined by 5-year increments, and cohorts were defined for each age group of each year with a 1-year shift. We used Bayesian APC analysis to decompose the changes in the diseases' mortality rates into age, period, and cohort effects. Results: The period effects for all diseases decreased during the analyzed periods for both men and women. The cohort effects for men increased substantially in cohorts born from around 1940 to the 1970s for all types of cardiovascular diseases. The cohort effects of HD decreased in the cohorts born in the 1970s or later for both men and women. Regarding IHD and CeVD, either a non-increase or decrease of cohort effects was confirmed for cohorts born in the 1970s or later for men, but the effects for women showed a continuously increasing trend in the cohorts born in the 1960s or later. Conclusions: The cohort effects for IHD and CeVD showed increasing trends in younger generations of women. This suggests that preventive approaches against cardiovascular diseases are needed, particularly for women.

A Literature study on the external treatment of nose diseases (鼻病의 外治法에 關한 文獻的 考察)

  • Park, Sang-Gyun;Rho, Sek-Seon
    • The Journal of Korean Medicine Ophthalmology and Otolaryngology and Dermatology
    • /
    • v.10 no.1
    • /
    • pp.139-158
    • /
    • 1997
  • A Literature study on the external treatment of nose diseases, the results are as follows; 1. Nose was called "Cheun-bin(天牝)", was outer orifice of the lung, was the gate of vital energe(氣), The main function of nose is divided three pacts. One is the respiration, another is the sense of smell, the other is the sounding consonance. 2. Nose is concerned with The Lung(肺), The Spleen(脾), The Heart(心), The Stomach(胃), The Large intestine(大腸), The Bladder(膀胱) in the organs, is concerned with Lung Meridean, Large intestine Meridean, Stomach Meridean, Heart Meridean, Spleen Meridean, Governor Vessel Meridean etc. 3. The method on the external treatment of nose diseases is classified with obstructive method, pouring method, blowing method, attaching method, plaster method, rubbing method, cleansing method, poulticing method. In frequency of practical use, Obstructive method is used 276 cases, Blowing method is used 123 cases, Attaching method is used 103 cases, Plaster method is used 76 cases. 4. In frequency of the medicinal works on the external treatment of nose diseases, Herba Asari(細辛) is used 134 cases, Pedicellus Melo(瓜 ) is used 85 cases, Radix Aconiti Praeparata(附子) is used 52 cases, Herba Agastachis(麝香) is used 51 cases, Semen Armeniacae Amarurn(杏仁) is used 44 cases etc. In frequency of a prescription on the external treatment of nose diseases, Tongcho-san(通草散) is used 9 cases, $Sesin-go{\cdot}Sinyi-go{\cdot}Changpo-san$ are used 8 cases, $Kwache-san{\cdot}Wungwhang-san$ are used 7 cases etc.

  • PDF

Open Heart Surgery for Congenital Heart Disease in Adult (성인 선천성 심장기형의 개심수술)

  • 구본원;허동명
    • Journal of Chest Surgery
    • /
    • v.29 no.9
    • /
    • pp.940-944
    • /
    • 1996
  • Patients over 15 years of age who have undergone a surgical correction of congenital heart disease at Kyungpook University Hospital during the period of January 1990 through October 1994 have been reviewed . One hundred forty three, 22.4 % of 628 operations, which have repaired congenital heart diseases during this period were adult patients. There were 23 patients under 20 years of age, 58 between 20∼29 years, 34 between 30∼39 years, 18 between 40∼49 years, and 10 between 50∼59 years. The most common defects were atrial septal defects which accounted for 73 cases (51.1 %) and other common anomalies were ven- tricular septal defects (57 cases, 39.9 %), tetralogy of Falloffs(4 cases, 2.8%) in order of incidence. There were 10 non-fatal operative complications (6.9 %) but there was no operative mortality. This study shows the incidence of operable congenital heart diseases in adults and the fact that it could be corrected surgically with low mortality and morbidity.

  • PDF